Literature DB >> 20805208

Vancouver's supervised injection facility challenges Canada's drug laws.

Kathleen Dooling1, Michael Rachlis.   

Abstract

Mesh：

Year:  2010        PMID： 20805208      PMCID： PMC2942917          DOI： 10.1503/cmaj.100032

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  10 in total

1.  Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users.

Authors:  Evan Wood; Thomas Kerr; Will Small; Kathy Li; David C Marsh; Julio S G Montaner; Mark W Tyndall
Journal:  CMAJ       Date:  2004-09-28       Impact factor: 8.262

2.  Safer injection facility use and syringe sharing in injection drug users.

Authors:  Thomas Kerr; Mark Tyndall; Kathy Li; Julio Montaner; Evan Wood
Journal:  Lancet       Date:  2005 Jul 23-29       Impact factor: 79.321

3.  Attendance at supervised injecting facilities and use of detoxification services.

Authors:  Evan Wood; Mark W Tyndall; Ruth Zhang; Jo-Anne Stoltz; Calvin Lai; Julio S G Montaner; Thomas Kerr
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

4.  Impact of a medically supervised safer injection facility on community drug use patterns: a before and after study.

Authors:  Thomas Kerr; Jo-Anne Stoltz; Mark Tyndall; Kathy Li; Ruth Zhang; Julio Montaner; Evan Wood
Journal:  BMJ       Date:  2006-01-28

5.  The law (and politics) of safe injection facilities in the United States.

Authors:  Leo Beletsky; Corey S Davis; Evan Anderson; Scott Burris
Journal:  Am J Public Health       Date:  2008-01-02       Impact factor: 9.308

6.  The Canadian government's treatment of scientific process and evidence: inside the evaluation of North America's first supervised injecting facility.

Authors:  Evan Wood; Thomas Kerr; Mark W Tyndall; Julio S G Montaner
Journal:  Int J Drug Policy       Date:  2008-06

7.  Impact of supply-side policies for control of illicit drugs in the face of the AIDS and overdose epidemics: investigation of a massive heroin seizure.

Authors:  Evan Wood; Mark W Tyndall; Patricia M Spittal; Kathy Li; Aslam H Anis; Robert S Hogg; Julio S G Montaner; Michael V O'Shaughnessy; Martin T Schechter
Journal:  CMAJ       Date:  2003-01-21       Impact factor: 8.262

8.  The cost-effectiveness of Vancouver's supervised injection facility.

Authors:  Ahmed M Bayoumi; Gregory S Zaric
Journal:  CMAJ       Date:  2008-11-18       Impact factor: 8.262

9.  Impact of a medically supervised safer injecting facility on drug dealing and other drug-related crime.

Authors:  Evan Wood; Mark W Tyndall; Calvin Lai; Julio S G Montaner; Thomas Kerr
Journal:  Subst Abuse Treat Prev Policy       Date:  2006-05-08

10.  Estimated drug overdose deaths averted by North America's first medically-supervised safer injection facility.

Authors:  M-J S Milloy; Thomas Kerr; Mark Tyndall; Julio Montaner; Evan Wood
Journal:  PLoS One       Date:  2008-10-07       Impact factor: 3.240
  10 in total
  4 in total

1.  Public health understandings of policy and power: lessons from INSITE.

Authors:  Patrick Fafard
Journal:  J Urban Health       Date:  2012-12       Impact factor: 3.671

2.  Increasing awareness about HIV prevention among young people who initiated injection drug use in a Canadian setting, 1988-2014.

Authors:  Anees Bahji; Evan Wood; Keith Ahamad; Huiru Dong; Kora DeBeck; M-J Milloy; Thomas Kerr; Kanna Hayashi
Journal:  Int J Drug Policy       Date:  2015-09-30

3.  The opioid crisis: past, present and future policy climate in Ontario, Canada.

Authors:  Kristen A Morin; Joseph K Eibl; Alexandra M Franklyn; David C Marsh
Journal:  Subst Abuse Treat Prev Policy       Date:  2017-11-02

4.  How to overcome political and legal barriers to the implementation of a drug consumption room: an application of the policy agenda framework to the Belgian situation.

Authors:  Pierre Smith; Louis Favril; Dominique Delhauteur; Freya Vander Laenen; Pablo Nicaise
Journal:  Addict Sci Clin Pract       Date:  2019-11-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.